Search

everythinglearnresearchcommunity

for

Search:↓

Psychosis can be an early sign of neuropsychiatric lupus, treatable with tailored medication.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

Higher disease activity in systemic lupus erythematosus is strongly linked to more internal organ damage.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Clofazimine effectively treated ashy dermatosis in a patient.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

A woman with both TLE and SLE improved with hydroxychloroquine treatment.

People with lupus and rheumatoid arthritis have thinner hair than healthy people.

Methotrexate side effects vary by race and sex.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Systemic steroids temporarily improve severe alopecia areata in children but often lead to relapse.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.